Lilly’s New Obesity Pill Wins Approval, but FDA Demands Extra Studies on Liver and Heart Risks
Eli Lilly’s newly approved weight-loss pill has cleared an important regulatory hurdle, but the U.S. Food and Drug Administration is requiring the company to carry out additional safety studies after launch, showing that regulators still want closer scrutiny of the medicine’s risks. Apparently, FDA asked Lilly for more data on possible liver injury linked to […]
